Exclusive 2026 Androxal Coupons: Up to 30% Discount

Big picture summary

Enclomiphene, sometimes discussed under the Androxal name, belongs to the selective estrogen receptor modulator class. In men who have an intact hypothalamic-pituitary-gonadal axis, enclomiphene can encourage the pituitary to secrete luteinizing hormone and follicle-stimulating hormone, which in turn stimulate testicular testosterone production.

• Disease focus - male secondary hypogonadism and related clinical features
• Common presentation - oral tablets or compounded capsules; availability is variable
• Reported strengths - preparations around 25 mg to 50 mg are commonly referenced

In the United States a widely available Androxal-branded product is not commonly seen in retail pharmacy chains. Access may occur through compounding pharmacies or specialized clinics. Take in the notes about legality and regulation in the USA along with the pricing plan information section for practical considerations.

Chief pharmacologically active ingredient data

Enclomiphene is the trans isomeric form of clomiphene citrate. It works by antagonizing estrogen receptors in the hypothalamus, reducing estrogen feedback and promoting release of LH and FSH. Run a comparisond with the zuclomiphene isomer, enclomiphene is often favored when the clinical aim is to raise endogenous testosterone in men.

For a description of the typical clinical context in which it may be used, consult the intended patients the current section.

This is intended for patients

Clinicians may consider enclomiphene for adult men with secondary hypogonadism, that is, low testosterone due to insufficient pituitary signaling rather than primary testicular failure. Unlike testosterone replacement, enclomiphene aims to restore the patient's own testosterone production.

When fertility preservation is a goal, patients and clinicians often discuss serologic the act of monitoring and other course options such as hCG or clomiphene citrate. If testes cannot respond because of primary failure, nonconventional treatment options should be considered; see other remedies and related medicines.

Dosing strategy guidance

Treatment plans are individualized. Examples found in clinical practice include doses in the 25 mg to 50 mg range, given daily or on an intermittent schedule. Your prescriber will recommend a regimen based on symptoms, laboratory data, and reproductive goals.

• Take at a consistent time each day, with or without food unless otherwise directed.
• Swallow tablets or capsules whole; only alter the form if a pharmacist confirms the product allows splitting or crushing.
• Do not change or stop the medication without medical advice. For one dose was skipped procedures, refer to the instructions. Steps to take after missing a dose.

Regular the act of monitoring of hormones and safety labs is typical; see legal and regulatory affairs briefs for common testing panels used in US practice.

Remedies for a dose was missed

If you miss one of your doses, take it as soon as you realize, unless the next dose is within close reach. If the next dose is near, skip the i missed the medication dose and stay on your regular plan. Do not stack two doses to make up for a i missed the medication dose.

Overdose risk information material

Exceeding the prescribed dose may produce nausea, vomiting, cranial ache, hot flashes, or visual disturbances. If an overdose deaths is suspected, seek emergency medical attention or contact Poison Control immediately at 1-800-222-1222 in the United States. Note that ovarian hyperstimulation is a concern in women and is not relevant to male patients.

Adverse pharmacologic effects

Undesirable unintended consequences are generally dose dependent and often resolve after discontinuation. Report severe, sudden, or persistent symptoms to your healthcare provider.

• Changes in vision such as blurring, floaters, or increased light sensitivity
• Pain in the head
• Gastrointestinal discomfort including nausea
• Mood alterations or increased irritability
• Hot flashes or episodes of flushing
• Acne or increased oiliness of the skin
• Tenderness in the breast

If visual symptoms occur, avoid driving or operating machinery and notify your prescriber promptly. For precautionary measures, see Safety instructions.

Pharmacotherapy the give and take of interactions in a system describe exchanges between components.

There are limited formal interplay between parties studies for enclomiphene. Drawing on the broader SERM experience, be cautious when combining with the following:

• Estrogen therapies or hormonal contraceptives that may oppose SERM activity
• Herbal products with estrogen-like properties such as concentrated phytoestrogens
• Certain immunosuppressants, for instance cyclosporine, where keeping track of metrics may be necessary
• Lipid-lowering agents; hormonal shifts can alter lipid panels
• Thyroid replacement therapy; adjustments in thyroid dosing warrant lab reassessment

Always give your pharmacist a full list of prescription, over-the-counter, and supplement items. For risk reduction strategiesinternal review Safety considerations.

Safety essentials

• Liver function - use caution and monitor liver enzymes in patients with hepatic impairment.
• Vision - stop activities that could be dangerous and contact a clinician if blurred vision, floaters, or light sensitivity appear.
• Thrombotic risk - SERMs may increase risk of blood clots; discuss personal clotting history with your provider.
• Hormone-sensitive malignancies - men with suspected or known prostate or breast cancer should not use agents that elevate testosterone without specialist oversight.
• Report new or worsening recurring headaches, abdominal pain, or mood changes promptly to your healthcare team.

Typical laboratory real time monitoring of systems in US clinical practice includes total and free testosterone, LH, FSH, estradiol, liver enzymes, lipid profile, and where relevant PSA and hematocrit. See Untoward effects for usual negative effects.

Situations that preclude therapy

Do not use enclomiphene if any of these apply:

• Known allergy to enclomiphene, clomiphene, or any inactive ingredient in the product
• Active or significant past liver disease
• Known hormone-dependent tumors; in men this includes suspected or confirmed prostate or breast cancer unless a specialist approves therapy
• Pregnancy or breastfeeding - relevant for female patients and a general class precaution

Certain red flags against use of this medication described for clomiphene in female-specific contexts are not applicable to men but remain part of the overarching safety information summary for SERMs. Review additional more options if enclomiphene is not appropriate.

Storing guidelines

• Keep medications in their original container with the lid secure.
• Store at room temperature, away from excessive heat, moisture, and direct sunlight; do not store in bathrooms.
• Keep out of reach of kids and animals.

Different treatment modalities and related medicines

Based on fertility goals, comorbidities, and laboratory results, prescribers may consider several alternate options:

• Clomiphene citrate (for example, generic clomiphene) - a related SERM commonly used off-label in men
• Human chorionic gonadotropin (hCG) - acts like LH to directly stimulate testicular testosterone production and is used when fertility is prioritized
• Aromatase inhibitors such as anastrozole - decrease conversion of testosterone to estradiol in select patients
• Tamoxifen - another SERM that can be tried when clomiphene is not tolerated
• Testosterone replacement therapy - injectable, transdermal, or oral options supply exogenous testosterone but generally suppress spermatogenesis and so are not ideal when near-term fertility is desired

Choice is individualized and guided by serial lab tests and patient priorities. See estimated costs in the price list section.

Typical wholesale pricing in the United States (USD)

Out-of-pocket costs vary by pharmacy, dose, location, insurance, and whether a product is compounded. The figures below represent broad monthly ranges only and are not guarantees.

• Generic clomiphene citrate - roughly $7 to $60 per month depending on dose and discounts
• Compounded enclomiphene (for example 25 mg daily) - roughly $80 to $220 per month
• hCG (prescription injectable) - roughly $90 to $300 per month depending on brand and dose
• Anastrozole (generic) - about $6 to $30 per month
• Tamoxifen (generic) - often in the $5 to $35 per month range
• Testosterone injections (generic testosterone cypionate) - medication costs around $30 to $120 per month; additional supplies and real time monitoring add expenses
• Transdermal testosterone gels or patches - commonly $140 to $550 per month without insurance

Insurance coverage, prior authorization requirements, and pharmacy networks strongly influence what the patient actually pays. For access pathways that affect availability and cost, consult the law and regulation notes.

Overview of US law and regulation

• Prescription requirement - SERMs such as clomiphene are prescription medications. An FDA-approved Androxal product is not commonly marketed in retail pharmacies; clinicians may use other approved drugs or rely on compounding where permitted.
• Controlled substance status - enclomiphene itself is not scheduled under the Controlled Substances Act, but valid prescribing and dispensing rules still apply.
• Compounding - state-licensed 503A pharmacies or 503B outsourcing facilities may compound enclomiphene; availability depends on federal and state regulations and individual pharmacy policies.
• Importation - importing prescription medication for personal use is restricted in many cases; the FDA may detain or refuse shipments without proper documentation and a valid US prescription.
• Telemedicine - prescribers must meet federal and state telehealth and e-prescribing rules. State-specific limitations and requirements may apply.
• Athletics and anti-doping efforts - many athletic authorities, including WADA and USADA, ban use of SERMs; competitive athletes should obtain clearance before you begin therapy.
• Clinical keeping track of metrics - common baseline and follow-up tests include total and free testosterone, LH, FSH, estradiol, liver enzymes, lipid profile, and selected cancer screening markers such as PSA where appropriate.

For clinical context, return to the Context and a concise overview of the uppermost partic alongside the Calculating doses and dosing protocol guidance.